Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)
Perspective Therapeutics (CATX) posted Operating Leases of $1.6 million for Q1 2026, up 54.43% sequentially from $1.0 million in Q4 2025, and up 32.2% YoY from $1.2 million in Q1 2025.
Perspective Therapeutics (CATX) Operating Leases (2019 - 2026) Analysis & Trends
Perspective Therapeutics has reported Operating Leases for 8 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Operating Leases rose 32.2% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 32.2% YoY) and the FY2025 annual result came in at $1.0 million, down 29.62% from the prior year.
- Operating Leases advanced to $1.6 million in Q1 2026 per CATX's latest filing, from $1.0 million in the prior quarter.
- Over five years, Operating Leases peaked at $1.7 million in Q3 2024 and troughed at $186000.0 in Q3 2022.
- A 5-year average of $975500.0 and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2023: Operating Leases tumbled 61.34% in 2022, then surged 743.55% in 2023.
- Over 5 years, Operating Leases stood at $186000.0 in 2022, then jumped by 319.35% to $780000.0 in 2023, then jumped by 83.08% to $1.4 million in 2024, then fell by 29.62% to $1.0 million in 2025, then surged by 54.43% to $1.6 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.6 million, $1.0 million, and $971000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 780,000.00 |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 805,000.00 |
| Mar 31, 2023 | 324,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Dec 31, 2021 | 392,000.00 |
| Sep 30, 2021 | 459,000.00 |
| Jun 30, 2021 | 524,000.00 |